James Mersch, a PhD candidate in Pharmaceutical and Pharmacological Sciences at the WVU School of Medicine, will present their Dissertation defense, “Development of novel SHP2 active-site inhibitors and demonstration of efficacy in preclinical models of HER2-positive breast cancer” on Wednesday, April 22, 2026, at 10:00 AM in HSC North 4080 also via ZOOM.  Please contact James Mersch at jem00037@mix.wvu.edu for the ZOOM meeting link.